- Home
- OSUR vs SRV Comparison
OSUR vs SRV Comparison
Compare OSUR & SRV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSUR
- SRV
- Stock Information
- Founded
- OSUR 2000
- SRV 2007
- Country
- OSUR United States
- SRV United States
- Employees
- OSUR N/A
- SRV N/A
- Industry
- OSUR Medical/Dental Instruments
- SRV Finance Companies
- Sector
- OSUR Health Care
- SRV Finance
- Exchange
- OSUR Nasdaq
- SRV Nasdaq
- Market Cap
- OSUR 231.1M
- SRV 191.0M
- IPO Year
- OSUR 1986
- SRV N/A
- Fundamental
- Price
- OSUR $2.45
- SRV $43.19
- Analyst Decision
- OSUR Hold
- SRV
- Analyst Count
- OSUR 1
- SRV 0
- Target Price
- OSUR $3.00
- SRV N/A
- AVG Volume (30 Days)
- OSUR 538.2K
- SRV 33.9K
- Earning Date
- OSUR 11-05-2025
- SRV 01-01-0001
- Dividend Yield
- OSUR N/A
- SRV 13.38%
- EPS Growth
- OSUR N/A
- SRV N/A
- EPS
- OSUR N/A
- SRV N/A
- Revenue
- OSUR $125,703,000.00
- SRV N/A
- Revenue This Year
- OSUR N/A
- SRV N/A
- Revenue Next Year
- OSUR $4.32
- SRV N/A
- P/E Ratio
- OSUR N/A
- SRV N/A
- Revenue Growth
- OSUR N/A
- SRV N/A
- 52 Week Low
- OSUR $2.30
- SRV $30.73
- 52 Week High
- OSUR $4.37
- SRV $44.30
- Technical
- Relative Strength Index (RSI)
- OSUR 30.66
- SRV 44.05
- Support Level
- OSUR $2.30
- SRV $41.01
- Resistance Level
- OSUR $2.51
- SRV $43.98
- Average True Range (ATR)
- OSUR 0.11
- SRV 0.81
- MACD
- OSUR -0.03
- SRV -0.00
- Stochastic Oscillator
- OSUR 20.00
- SRV 45.13
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.
About SRV NXG Cushing Midstream Energy Fund of Beneficial Interest
NXG Cushing Midstream Energy Fund is a non-diversified, closed-end management investment company with an investment objective of seeking a high after-tax total return from a combination of capital appreciation and current income. The fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in midstream energy investments.